查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402593

药物滥用治疗市场：按滥用类型、按药物类型、按分销管道、按地区

Drug Abuse Treatment Market, By Abuse Type, By Drug Type, By Distribution Channel, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球药物滥用治疗市场预计将从 2023 年的 357.4 亿美元增加到 2030 年的 207 亿美元，预测期内年复合成长率(CAGR)为 8.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 207亿美元
实际资料 2018-2021 预测期 2023-2030
预测期复合年增长率 8.10% 2030年市场规模预测 357.4亿美元
图 1. 2023 年全球市场占有率(%)（按地区）
药物滥用治疗市场-IMG1

近年来，全球药物滥用治疗市场经历了显着成长。药物滥用疾病的盛行率不断上升，主要是由于非法药物的供应增加，以及精神健康问题的盛行率不断上升，因此需要有效的治疗方案。此外，人们对成瘾治疗的各种药物和心理治疗的认识不断提高，导致更多的人寻求专业帮助。扩大针对药物滥用的健康保险覆盖范围以及促进治疗计划的各种政府措施也刺激了市场扩张。然而，与毒瘾相关的社会耻辱继续阻止许多患者积极寻求可用的治疗方案。

市场动态：

全球药物滥用治疗市场主要是由全球药物滥用疾病的流行所推动的。最近的估计表明，到 2023 年，全球将有超过 3,100 万人受到药物滥用障碍的影响。由于贩运网络的兴起和社会接受度的提高，毒品的供应量增加，导致消费率上升。此外，忧郁症和焦虑等心理健康问题的增加往往导致个人产生药物依赖，这也使治疗提供者受益。针对古柯碱、酒精、鸦片类药物和大麻成瘾的各种药物和心理治疗也推动了需求。然而，门诊復健计画对许多患者来说费用昂贵，财务限制是主要的阻碍因素。缺乏社会支持也是一些地区成功復原的障碍。然而，政府透过有利的法规和宣传宣传活动提供的支持为市场的持续成长提供了有利的机会。

本研究的主要特点

  • 该报告对全球药物滥用治疗市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球药物滥用治疗市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球药物滥用治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球药物滥用治疗市场的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 新药开发
    • 与药物滥用相关的社会耻辱
    • 市场相关人员策略合作
  • 主要亮点
  • 监管场景
  • 最近的趋势
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 合併、收购和合作

第四章全球药物滥用治疗市场－冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章 全球药物滥用治疗市场，依滥用类型，2018-2030 年

  • 酒精成瘾
  • 烟草/尼古丁成瘾
  • 阿片类药物成瘾

第六章全球药物滥用治疗市场，依药物类型，2018-2030

  • Disulfiram
  • Acamprosate
  • 纳曲酮
  • 美沙酮
  • Buprenornhine
  • 尼古丁成瘾的治疗
  • 尼古丁替代疗法
  • 非尼古丁药物
  • 其他的

第七章 全球药物滥用治疗市场，依通路，2018-2030 年

  • 医院药房
  • 零售药房
  • 网路药房

第八章全球药物滥用治疗市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 竞争形势

  • 公司简介
    • Cipla Limited
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan NV
    • Odyssey Pharmaceuticals Inc.
    • Lil'Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.
    • DXC Technology Company
    • GenoLogics

第10章

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI2011

Global drug abuse treatment market is expected to reach US$ 20.70 Bn by 2030, from US$ 35.74 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 20.70 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.10% 2030 Value Projection: US$ 35.74 Bn
Figure 1. Global Drug Abuse Treatment Market Share (%), By Region, 2023
Drug Abuse Treatment Market - IMG1

Global drug abuse treatment market has been witnessing significant growth in the recent years. Rising prevalence of substance abuse disorders mainly due to easy availability of illicit drugs and growing mental health issues have necessitated effective treatment options. Moreover, increasing awareness about various pharmacological and psychological therapies for addiction treatment is driving more individuals to seek professional help. Various government initiatives promoting treatment programs along with growing health insurance coverage for substance abuse are also fueling the market expansion. However, social stigma associated with drug addiction continues to deter many patients from actively pursuing the available treatment options.

Market Dynamics:

Global drug abuse treatment market is primarily driven by growing substance abuse disorder prevalence worldwide. According to recent estimates, over 31 Mn people globally suffer from substance use disorders in 2023. Easy accessibility of drugs due to flourishing trafficking networks and rising social acceptance has resulted in higher consumption rates. Moreover, increasing mental health problems such as depression and anxiety often lead individuals towards substance dependency, thereby benefitting treatment providers. Various pharmacological and psychological therapies available for cocaine, alcohol, opioid, and cannabis addiction are also boosting the demand. However, financial constraints constitute a major restraint with outpatient rehab programs being costly for many patients. Lack of social support also acts as an impediment for successful recovery in a few regions. Nonetheless, government support through favorable regulations and public awareness campaigns present lucrative opportunities for sustained market growth.

Key features of the study:

  • This report provides in-depth analysis of the global drug abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global drug abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store Products Inc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., and British American Tobacco Plc., Alkermes, Sun Pharmaceuticals, Dr. Reddy's Laboratories, BioCorRx, Inc., DXC Technology Company, and GenoLogics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global drug abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug abuse treatment market

Detailed Segmentation:

  • Global Drug Abuse Treatment Market, By Abuse Type
    • Alcohol Dependence
    • Tobacco/Nicotine Addiction
    • Opioid Addiction
  • Global Drug Abuse Treatment Market, By Drug Type
    • Disulfiram
    • Acamprosate
    • Naltrexone
    • Methadone
    • Buprenorphine
    • Nicotine Addiction Treatment
    • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
    • Non-Nicotine Medication
    • Bupropion
    • Varenicline
    • Others
  • Global Drug Abuse Treatment Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Drug Abuse Treatment Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Global Drug Abuse Treatment Market:
    • Cipla Limited
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan N.V.
    • Odyssey Pharmaceuticals Inc.
    • Lil' Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Abuse Type
    • Market Snippet, By Drug Type
    • Market Snippet, By Distribution Channel
    • Market Snippet ,By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Novel drug development
    • Social stigma associated with drug abuse
    • Strategic collaboration between market players
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Drug Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Drug Abuse Treatment Market, By Abuse Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Alcohol Dependence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Tobacco/Nicotine Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Opioid Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Drug Abuse Treatment Market, By Drug Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Disulfiram
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Acamprosate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Naltrexone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Methadone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Buprenorphine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nicotine Addiction Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
  • Non-Nicotine Medication
    • Bupropion
    • Varenicline
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Drug Abuse Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Drug Abuse Treatment Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
    • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Company Profile
    • Cipla Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan N.V.
    • Odyssey Pharmaceuticals Inc.
    • Lil' Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.
    • DXC Technology Company
    • GenoLogics
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us